Related Experiment Video
Updated: Oct 31, 2025

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Impact of innovation in oncology: more questions than answers
Gianpiero Fasola1,2, Maria Carla Barducci3, Giordano Beretta4,5
1Oncology Department, University Hospital S. Maria della Misericordia, Udine, Italy.
Abstract:
Oncology is going through the fastest innovation period in the history of medicine and a growing number of patients improve or experience increased chances of survival. The declining death rate, starting from 1991, resulted in 2.9 million deaths avoided in the United States so far. A growing prevalence of patients is observed in all Western countries. New cancer drug approvals between 2000 and 2016, linked to other diagnostic, surgical, and health care improvements, were significantly associated with death reduction for the most common cancers. Alongside many positive aspects, other effects of innovations in oncology also deserve attention, especially challenges associated with the substantial increase of knowledge volume, the sharp growth of prevalence, and a concomitant or consequent increase in clinical, social, and organizational complexity. We analyse some of the consequences of oncology innovation on healthcare systems and professionals and present some suggestions on how these could be addressed by healthcare systems.
Insights
Oncology innovations are improving cancer survival rates and reducing deaths. However, these advancements increase healthcare complexity, requiring system-level adaptations for professionals and patients.
Area of Science:
- Oncology
- Medical Innovation
- Healthcare Systems
Background:
- Oncology is experiencing unprecedented innovation, leading to improved patient survival and reduced cancer mortality since 1991.
- New cancer drug approvals and advancements in diagnostics and treatment have significantly decreased death rates for common cancers.
- Increasing cancer prevalence is observed across Western countries, highlighting a growing patient population.
Discussion:
- The rapid pace of innovation in oncology generates a vast volume of new knowledge.
- The expanding prevalence of cancer survivors presents unique clinical, social, and organizational challenges.
- Healthcare systems face increased complexity due to these concurrent trends in oncology.
Key Insights:
- Medical innovations in oncology have demonstrably reduced cancer-related deaths.
- The growing number of cancer survivors necessitates a re-evaluation of healthcare delivery models.
- Increased complexity in oncology care impacts healthcare professionals and system efficiency.
Outlook:
- Healthcare systems must adapt to manage the growing volume of oncological knowledge and patient prevalence.
- Strategies are needed to address the clinical, social, and organizational complexities arising from oncology advancements.
- Proactive adjustments in healthcare systems are crucial to sustain and optimize the benefits of cancer innovation.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

